Scientists will pay you £3,250 to get infected with flu as part of a drug trial.
Healthy 18 to 55-year-olds are being invited to take part in a human challenge study, which will see them infected with H3N2 — the most common strain in the UK.
The virus will be sprayed into at least 100 volunteers’ noses, after which they will stay in a hotel-style facility in Whitechapel, London, for 14 nights.
Open Orphan (LON:ORPH) was founded in 2017, with the goal of rapidly building Europe’s leading pharma services company by a management team with extensive industry and financial expertise. The company comprises of two commercial specialist CRO services businesses (Venn Life Sciences and hVIVO) and is also developing a genomics data platform business (Genomic Health Data).